chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At approximately 1150, patient arrived at facility. Patient reported she received a booster dose of Pfizer Covid Vaccine (LOT# FF2587, exp. 12/2021) on 09/29/21 in left arm. Patient did not have her original vaccination card for her appointment on 09/29/21. Patient brought her original vaccination card and requested facility to write her booster dose on her original vaccination card. Patient presented her original vaccination card to immunization registry staff. Immunization registry staff inspected patient's original vaccination card. Immunization registry staff immediately reported to Lead Nurse. Lead Nurse inspected original vaccination card. Patient received a 1st dose of Moderna Covid Vaccine (LOT# 007M20A, exp. 7/14/21) on 02/12/2021. Patient also received a 2nd dose of Moderna Covid Vaccine (LOT# 002B21A, exp. 09/07/21) on 03/12/2021. Immunization registry staff searched patient on immunization registry. Patient's immunization registry profile matched with patient's original vaccination card. Lead Nurse elevated situation to Vaccine Operations Leads. Vaccine Operations  reviewed incident with Lead Nurse. Staff nurse informed patient regarding incident. Staff nurse assessed patient. Patient denied itchiness, rashes, hives, difficulty swallowing, and difficulty breathing after vaccination. Patient reported fatigue and and a sore left arm after vaccination. Staff nurse educated patient on the difference between an additional and booster dose, signs/symptoms of when to seek emergency care, to sign up on v-safe, and to follow up with her primary care provider. Immunization registry staff gave patient a new vaccination card according to her immunization registry profile. At approximately 1505, patient left facility with unlabored respirations and steady gait.
Patient reports feeling unwell for approximately 2 weeks, but began having fevers, body aches, and chills about 5-6 days prior to ED presentation. Also reports cough and headache. Patient hypoxic to 87% requiring 2L O2 via nasal cannula. Patient febrile at 101.4 F. Patient to be admitted to the hospital. The patient has received dexamethasone, along with medications for symptom management including acetaminophen, ketorolac, and benzonatate.
hot flash; diarrhea; feeling sick; nausea; chills; vomiting; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flash), DIARRHOEA (diarrhea), MALAISE (feeling sick), NAUSEA (nausea) and CHILLS (chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018BZ1A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DILTIAZEM, METOPROLOL, METFORMIN, SIMVASTATIN, DIGOXIN, FUROSEMIDE (LASIX [FUROSEMIDE]), MAGNESIUM and SITAGLIPTIN (JANUVIA [SITAGLIPTIN]) for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced FATIGUE (fatigue). On 09-Apr-2021, the patient experienced HOT FLUSH (hot flash), DIARRHOEA (diarrhea), MALAISE (feeling sick), NAUSEA (nausea), CHILLS (chills) and VOMITING (vomiting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Apr-2021, FATIGUE (fatigue) had resolved. At the time of the report, HOT FLUSH (hot flash), DIARRHOEA (diarrhea), MALAISE (feeling sick), NAUSEA (nausea), CHILLS (chills) and VOMITING (vomiting) outcome was unknown.            No treatment information was reported. Events are red arm, itchy arm.   This case was linked to US-MODERNATX, INC.-MOD-2021-073649 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073649:
Flu like symptoms - coughing, running nose, etc. Began a couple days after getting shot.
Developed vague right shoulder pain and subsequent weakness. Seen in clinic approx 11 days later with persistent pain symptoms and developing weakness. Concern for Parsonage Turner syndrome (neuralgic amyotrophy), which was confirmed on 10 Jan 2019 with EMG/nerve conduction studies performed by Neurology clinic. On follow-up in clinic 4 Feb 2019, pain in shoulder was improved, weakness persisted, but pain had shifted to distribution consistent with musculocutaneous nerve. Given continued pain and confirmed diagnosis of neuralgic amyotrophy, decision made to treat with 2 week prednisone course. On follow-up by phone on 26 Mar 2019, pt reported that pain and mobility of her right arm were improving, as well as weakness but some weakness still persisted.
After a few minutes of waiting post vaccine administration. Mom reports that pt started perspiring so mom escorted her to the water fountain for a drink, but perspiring persisted so mom altered Pedi Reception staff who in turn notified me of pt's symptom. Mom and I escorted pt to triage room. Pt was pale, weak, damp all over from sweat, very quiet, however when asked how she felt said her stomach "feels funny". I lay pt supine on exam table. Vital signs stable. Pt drank about  half-cup of water; then another half-cup of water a while later. Damp cloth applied to forehead. PCP notified. She evaluated pt and after rpt confirmed she was feeling a little better and her skin color improved, head of bed raised a bit and BP rechecked - normal range. After another 5 minutes pt sat upright and BP rechecked - again in the normal range. Medically cleared by PCP and left with instruction to contact PCP office if any further concerns or questions.
pt c/o tingling in left hand and fingers. Benadryl 50mg po given to patient, b/p 122/70, pulse 55 @ 4:24, b/p checked x 4 times, every 5 minutes, b/p and pulse remained around 120-130/70-77 pulse remains in the high 50's. Pt was released to husband to return home. Encouraged to f/u with PCP about event. Telephone call to pt around 6:45, pt states she was doing well, still had tingling in left hand and fingers. Denied any other symptoms.
Mild diarrhea the day after injection. Could be coincidental. Cleared up in a few hours.  Mild soreness at injection site.
I began having a burning sensation in my nose and sinuses, which got a little worse. I then started having major headaches that would last all day long; I got these for at least four or five days. I also had body aches all over. I also sweated profusely, and I soaked the bed. I had a fever, cough, runny nose, and both sinus and chest congestion. On 7/7/2022, I got a positive result on a home antigen test. On the same day, I also underwent a rapid PCR test at a testing site, and the result was positive. I received a monoclonal antibody infusion at a local hospital on 7/8/2022. The COVID-19 had me down for about two. It's been almost a year, and I feel like I haven't made a full recovery. I am tired and don't have as much energy as I did before the COVID-19. I can get a full night's sleep, and I can still wake up exhausted.
Approximately 20 hours after vaccination pt stated that she fainted. When she regained consciousness she said her head felt "itchy", she had palpitations and felt "weird". She said she took one of her anti-anxiety tablets (alprazolam) and began to feel better. She had someone come to stay with her to observe her but that she was feeling better. She was advised to see medical treatment if symptoms returned.
About 9 days ago I started out with a sore throat, head congestion, and a really bad cough.  I called in to the doctor once I lost my sense of smell.  The doctor prescribed Pearls, Mucinex, and Albuterol.  All of my home COVID-19 test have come back negative.  I do not have any body aches at all.  I was in the shower and I use a pungent body wash and I could not smell it and I have never had that happen before.  I am on the mend today but I still have a solid cough, but I do feel like I am getting better but still coughing.
Patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021; Patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 10:54 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 10:54 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 60.66 years.  Concomitant products were not provided.  On 03-Apr-2021, 20 vials were moved to clinic.   On 30-Mar-2021, the vaccines were moved to fridge.  Proposed beyond use date was 29-Apr-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit.  On the date of administration, at 09:00 A.M., the temperature recorded was 34 Fahrenheit that has been reached by the vial.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  The vial was not in a frozen state at the time of vaccine administration.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.   This case was linked to MOD-2022-566976 (Patient Link).
Chills, fever, stomach upset, dizziness, rash over entire body, brain fog
Case number PHEH2012US014130 is an initial spontaneous report received from a physician on 17 Jul 2012 along with a follow-up received on 08 Aug 2012: This report refers to an 11-years-old male patient whose medical history, past drugs, current conditions and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M11053 and expiry date: Feb 2014) intramuscularly on to right arm along with GARDASIL (other manufacturer, batch number: 0555AE) on 12 Jul 2012. It was reported that he experienced swelling to the elbow and up through the shoulder and to the nipple on the chest on 13 Jul 2012. He was seen by physician on 16 Jul 2012 and was prescribed antibiotics (unspecified). The outcome of the event was reported as complete recovery of the patient. The causality was not assessed. No further information was available. Follow-up received from the physician on 08 Aug 2012: Updated suspect product information for GARDASIL, expiry date of MENVEO and outcome.
Pain and tightness in chest and throat starting about 7-8 minutes after infection. Facial and lip numbness starting about 25 minutes after injection. Pain in chest and throat lasted hours into the night until I fell asleep. Woke up the next day with zero symptoms.
patient felt dizzy and feeling of vertigo about 10 minutes after the shot. she had some food to avoid and possible hypoglycemia as a reason behind it.  And then asked for help .She was monitored for 30 min . In the meantime she was offered to call EMS , but she refused ( was not neccessary , she was coherent, and able to sit )  She had a back procedures between the 2 doses and also reported suffering from ocular migraines  sometimes. After drinking some water and pedialyte she felt better and left accompanied from her husband .  Made a cortesy call at 7:00 pm and the patient was already feeling better. The symptoms had lasted for about 1 hour.
11x9 erythema, induration, warm, tender 2 days p/vax given;tx ice, HC cream;
when she lays down she feels shock on her heart; got a cough; she has the worst runny nose; This case was reported by a consumer via call center representative and described the occurrence of cardiac discomfort in a adult female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced cardiac discomfort, cough and runny nose. On an unknown date, the outcome of the cardiac discomfort, cough and runny nose were unknown.   It was unknown if the reporter considered the cardiac discomfort, cough and runny nose to be related to Shingles vaccine.  Additional details were provided as follows: The reporter is patient's grandchild. The age at vaccination was not reported. The patient got the vaccine and then got a cough, when she layed down she felt shock on her heart and had the worst runny nose. The reporter wanted to know the side effects after shingles vaccine.
fever, chills, body aches x 2 days.  Started 3 hours after injection
Itching at site occurred  ~36 hours after shot and redness at site the size of a golf ball ~50 hours after shot.
This spontaneous report as received from a nurse refers to a 15 year old female patient with SULFA allergy. On 09-JAN-2017, the patient was vaccinated with a dose of GARDASIL 9, lot # reported as M034780, expiration date 15-APR-2019, intramuscular (dose and site of administration were not reported) for prophylaxis. There were no concomitant medications. On 18-JAN-2017, the patient experienced violent seizure. The patient was taken to the emergency room. A computerized tomogram scan was performed at the hospital and the result was normal. The outcome of seizure was reported as fully recovered in approximately January 2017. The relatedness between the event and GARDASIL 9 was not reported. Upon internal review, the event of seizures was considered to be medically significant. Additional information has been requested.
Day 1 felt like my arm was in extreme pain, resolved a little over 24 hours. Day 2 I woke feeling like someone attacked the left back of my head with a hammer. It's now day 4 and my head still feels like a watermelon, about to explode. Tried migraine meds no help,  heat send to be the only partial relief available.
Fist-size red "bruise", achy on Day 1,  Area periodically itches, prickles or aches - rash briefly if I scratch it Occasional sharp pain in the area Still present 2 weeks later Cold sores around the mouth after the first week.  Still present.  Treated with abreve.
Loud ringing in ears. Reduced hearing ability. Vertigo.  This started after two days of fever after first vaccination 3/18/2021.
Moderately sore arm following injection. About 14 hours after vaccination, began to experience flu-like symptoms: severe back pain, moderate pain in all joints from head to toe, chills surging through my body every time I moved, severe headache, aching back of neck, nausea, debilitating weakness, fatigue to the point I could not get out of bed. Headache was so bad I could not read, wear glasses, or even keep my eyes open for very long. I felt VERY ill, the worst I have ever felt in my entire life. Flu-like symptoms lasted almost exactly 24 hours. Low-level fatigue persisted past 24 hours. Regardless of this bad experience, I am happy to have been vaccinated and suffer through a short bout of side-effects rather than come down with COVID-19. I would certainly make the same choice again.
not feeling well; Initial information received on 30-Oct-2021 regarding an unsolicited valid social media non-serious case received from a consumer or non-healthcare professional via Regulatory Authority.  This case involves a patient (unknown demographic) who had not feeling well (malaise) after receiving INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor.  The patient medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious not feeling well (malaise) (unknown latency) following the administration of INFLUENZA VACCINE.  it was reported "Got mine and was not feeling well."  There were no lab data/results available.  It was unknown if the patient experienced any additional symptoms/events.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
Information has been received from a physician concerning a female (age not reported) who was vaccinated with the first 0.5 mL dose of GARDASIL (lot # not reported). On approximately 23-APR-2008 "last week" the patient fainted after getting the first dose of GARDASIL (lot # not reported). The patient recovered. Additional information has been requested.  10/08/2008 This is in follow-up to report(s) previously submitted on 5/14/2008. Follow up information was received on 19-JUN-2008. The registered nurse reported that the patient was vaccinated IM in the right deltoid with the first dose of GARDASIL (lot # 657617/0384U) on 10-JUL-2007. On the same day the patient was vaccinated SQ in the left arm with a dose of MMR II (lot # 654685/0987F), IM in the right deltoid with the first dose of VAQTA (lot # 657306/0360U) and IM in the left deltoid with a dose of DTAP (lot # C2455AA). It was reported that the patient fainted after given the first dose of GARDASIL. It was reported that it was the last shot given out of 4 shots. The registered nurse had the patient lie on her back on the exam bed. She fainted while sitting up and she came to right after. The patient recovered on 10-JUL-2007. The patient is allergic to amoxicillin. Additional information has been requested.
ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/25/2023 ACUTE BRONCHITIS  HYPOXIA 3/24/2023 ACUTE BRONCHITIS
Approximately 2 months and a half after my 4th dose I contracted COVID-19 and have the following symptoms: Fatigue and minor nasal congestion. I have not been taking any medications for treatment but I called my doctor's office to request a prescription of PAXLOVID but have not heard from them yet. As of today 06/09/2022, I am still experiencing the same symptoms.
pain (body ache); Feels like need sleep; Hard at the touch; Swelling and hard at the touch; Very hot at the touch; Arm pain/ Soreness in the arm/ Arm hurt so bad like surgery; Overall tiredness; Headache; Arm pain and rash and very hot at the touch; Chilling and shaking; Severe nausea; Cold; Chilling and shaking; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain (body ache)), SOMNOLENCE (Feels like need sleep), INDURATION (Hard at the touch), SWELLING (Swelling and hard at the touch) and FEELING COLD (Cold) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 31M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PYREXIA (Fever). On 14-Feb-2021, the patient experienced FEELING COLD (Cold), TREMOR (Chilling and shaking), CHILLS (Chilling and shaking) and NAUSEA (Severe nausea). On an unknown date, the patient experienced PAIN (pain (body ache)), SOMNOLENCE (Feels like need sleep), INDURATION (Hard at the touch), SWELLING (Swelling and hard at the touch), FEELING HOT (Very hot at the touch), PAIN IN EXTREMITY (Arm pain/ Soreness in the arm/ Arm hurt so bad like surgery), FATIGUE (Overall tiredness), HEADACHE (Headache) and RASH (Arm pain and rash and very hot at the touch). On 14-Feb-2021, CHILLS (Chilling and shaking) outcome was unknown. At the time of the report, PAIN (pain (body ache)), SOMNOLENCE (Feels like need sleep), INDURATION (Hard at the touch), SWELLING (Swelling and hard at the touch), FEELING COLD (Cold), TREMOR (Chilling and shaking), FEELING HOT (Very hot at the touch), PAIN IN EXTREMITY (Arm pain/ Soreness in the arm/ Arm hurt so bad like surgery), FATIGUE (Overall tiredness), PYREXIA (Fever), HEADACHE (Headache), NAUSEA (Severe nausea) and RASH (Arm pain and rash and very hot at the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       The Patient was given Medications for body aches and acetaminophen for fever. Concomitant medications were not reported.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. Rash, chills, headache, fever,  fatigue and nausea are consistent with the product safety profile
Child reported to clinic 25 Nov. 2002. Fever and generalized macullopapular rash started on 24 Nov. 2002. Child diagnosed with chicken pox. Received Varivax 14 Nov. 2002. Being treated
Patient had history of shingles in Sept of '06 and had post-herpetic neuralgia which he was being treated for.  His pain was controlled prior Patient was vaccinated with Zostavax and 2-3 days later had significant increase in pain and sensitivity at the site of original shingles infection.  Patient reports that the area appeared to be more red than usual.  The site of pain was in the mid chest area under right breast and around to the back area.
Red, warm to touch, swollen at site with rings around it. (Baseball size redness).
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. In January 2013 the patient was vaccinated with the first dose of ROTATEQ (orally, dosage strength not reported), followed by second dose of ROTATEQ in approximately March or April 2013. It was also reported that the patient was vaccinated with M-M-R II (dose, route, indication and strength not reported) at the age of seven months. The reporter stated that the patient was "irritable" after receiving the first dose of ROTATEQ. On an unknown date the patient recovered. The relatedness between suspect therapies and irritability was not reported. Additional information has been requested.
Ear pressure, vertigo and dizzyness, ringing. Left ear only. Sudafed and Afrin, lots of water.   Little change after 7 days, less vertigo but still ringing and pressure